Gastrointestinal Stromal Tumors Increased in Past 20 Years
Drug Topics
NOVEMBER 7, 2024
Researchers attempted to understand the evolving epidemiology of gastrointestinal stromal tumors in major organ sites.
Thu.Nov 07, 2024
281 
Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in
PharmaVoice
NOVEMBER 7, 2024
Dealmaking this year has been largely muted, but M&A trends are pointing to the areas where pharma is placing the most emphasis.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Q&A: Pharmacists Champion Nonopioid Pain Management Strategies
Drug Topics
NOVEMBER 7, 2024
Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.
Healthcare Email Marketing Strategies: A Guide for Pharma Executives
Pharma Marketing Network
NOVEMBER 7, 2024
In today’s digital world, healthcare email marketing is more than just sending out newsletters. It’s a strategic tool that, when done right, can boost engagement, nurture relationships with healthcare professionals (HCPs), and increase brand awareness. But how can pharma companies truly maximize the potential of email marketing? Let’s dive in and explore some proven strategies.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Q&A: Key Things Pharmacists Need to Know About Insulin Icodec
Drug Topics
NOVEMBER 7, 2024
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses a recent meta-analysis that evaluated the efficacy, safety, and clinical implications of insulin icodec.
Buspirone alternatives: What can I take instead of buspirone?
The Checkup by Singlecare
NOVEMBER 7, 2024
Buspirone (formerly available under the brand name Buspar ) is a generic prescription medication used to help manage generalized anxiety disorder (GAD) and treat symptoms of anxiety. Buspirone may also be used off-label for major depressive disorder. As an anxiolytic drug, buspirone is believed to lower anxiety by regulating serotonin and dopamine receptors in the brain.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Is nausea a symptom of diabetes?
The Checkup by Singlecare
NOVEMBER 7, 2024
Diabetes mellitus is a chronic condition that causes high blood sugar levels. As the body struggles to control elevated blood glucose, you may experience increased thirst, frequent urination, and fatigue. Vision changes, dehydration, and slow-healing sores can also occur. Although it’s not a direct cause of diabetes, nausea can occur due to blood sugar fluctuations and other diabetes complications.
Implementation of Supply-Related Restrictive Measures Reduces IVIG Use
Pharmacy Times
NOVEMBER 7, 2024
Efforts include a mandatory intravenous immunoglobulin ordering form, blood bank gatekeeping, and a stewardship committee to ensure optimized use.
Master Pharmacy Cash Flow with These 3 KPIs
DiversifyRx
NOVEMBER 7, 2024
The pharmacy cash flow crisis for independent pharmacy owners is NOT over! Master these 3 KPIs and dramatically improve your cash flow before the end of the year. The so-called DIR Fee Apocalypse may be over, but don’t let that give you a false sense of security. For many independent pharmacy owners, pharmacy cash flow remains THE #1 PROBLEM. It’s pushing some owners to close their doors or drown in debt.
Risk of Developing Eosinophilic Esophagitis Is Higher in Pediatric Patients With Atopic Conditions
Pharmacy Times
NOVEMBER 7, 2024
Children with certain atopic conditions, including asthma and common food allergies, were observed to have a higher risk of developing the chronic disorder.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
These 6 companies are using AI to streamline clinical trials for pharma
STAT
NOVEMBER 7, 2024
In the last year, drugmakers have talked up the prospect of medicines discovered or designed by artificial intelligence.
An RNAi renaissance is creating a new generation of startups
PharmaVoice
NOVEMBER 7, 2024
Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is building on that foundation by taking the drugmaking technology in new directions.
Quest Diagnostics expands network partnership with Anthem plans
Fierce Healthcare
NOVEMBER 7, 2024
Quest Diagnostics and Elevance Health are broadening their partnership into four more states with the goal of making it easier for patients to access in-network laboratory services. | Quest Diagnostics and Elevance Health are broadening their partnership into four more states, with the goal of making it easier for patients to access in-network laboratory services.
Preventive Biologics May Aid the Antibiotic Resistance Crisis
Pharmacy Times
NOVEMBER 7, 2024
New technology and innovation may help turn the corner on antibiotic resistance.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
General Catalyst's HATCo moves forward on $485M Summa Health deal
Fierce Healthcare
NOVEMBER 7, 2024
Venture capital firm General Catalyst's Health Assurance Transformation Corporation (HATCo) signed a definitive agreement to buy Summa Health for $485 million, the organizations announced Thursday. | Venture capital firm General Catalyst's Health Assurance Transformation Corporation signed a definitive agreement to buy Summa Health for $485 million, the organizations announced Thursday.
FDA Proposes Removal of OTC Oral Phenylephrine From Cough/Cold Products
Pharmacy Times
NOVEMBER 7, 2024
Evidence shows that the agent is not an effective nasal decongestant.
Sarepta pulls plug on Duchenne exon-skipping drug
pharmaphorum
NOVEMBER 7, 2024
Sarepta has halted development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy therapy Exondys 51.
Lerodalcibep Delivers Significant LDL-C Reduction for High-Risk Cardiovascular Patients
Pharmacy Times
NOVEMBER 7, 2024
Lerodalcibep is a novel, third-generation, anti-PCSK9 therapy small binding protein.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Webinar recap: Boosting recruitment and retention with SDOH data
pharmaphorum
NOVEMBER 7, 2024
Discover the key takeaways from a webinar focused on boosting recruitment and retention through Social Determinants of Health (SDOH) data. Learn how incorporating SDOH data can enhance your recruitment and retention strategies.
EMA approves Sanofi/Regeneron’s Dupixent for young EoE patients
Pharmaceutical Technology
NOVEMBER 7, 2024
The EMA has granted approval for Sanofi/Regeneron’s Dupixent (dupilumab) to treat EoE in children as young as one.
Avid Bioservices to go private in $1.1bn private equity deal
pharmaphorum
NOVEMBER 7, 2024
Nasdaq-listed CDMO Avid Bioservices has agreed a $1.
Researchers Highlight Need for Increased RSV Vaccination
Pharmacy Times
NOVEMBER 7, 2024
RSV vaccines were 80% effective in preventing hospitalization, ICU admission, and death among adults aged 60 years and older.
Blueprint's mastocytosis drug Ayvakit cleared for NHS use
pharmaphorum
NOVEMBER 7, 2024
NICE has recommended broad use of Blueprint Medicines' recently-approved therapy for rare blood disorder advanced systemic mastocytosis
Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist
Outsourcing Pharma
NOVEMBER 7, 2024
Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.
Minister for Science champions partnerships with private clinical sector in UK
Pharmaceutical Technology
NOVEMBER 7, 2024
Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.
Aditum Bio and Leads Biolabs Form New Company, Oblenio Bio, for Developing a Therapeutic Antibody to Treat Autoimmune Disorders
BioPharm
NOVEMBER 7, 2024
Under an agreement, Leads Biolabs has granted the new company, Oblenio Bio, an exclusive option to license LBL-051, a tri-specific T-cell engager antibody.
DBV Technologies’ stock slides as financial woes worsens
Pharmaceutical Technology
NOVEMBER 7, 2024
The company reported that it does not have sufficient cash reserves to operate for the next 12 months, can only fund operations into Q1 2025.
Metrics for the UK’s VPAG: A work in progress
pharmaphorum
NOVEMBER 7, 2024
Discover the latest metrics and updates on the UK's VPAG (Voluntary scheme for branded medicines Pricing, Access and Growth) from NICE (National Institute for Health and Care Excellence). Stay informed on this work in progress.
More turbulence at Aurinia as autoimmune drugmaker lays off 45% of workforce
Fierce Pharma
NOVEMBER 7, 2024
After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting to restructuring. | After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting to restructuring, cutting the autoimmune disease biotech's workforce for a second time in less than a year.
Addressing Racial Disparities in Opioid Prescriptions: The Role of Pharmacists in Achieving Equity
Pharmacy Times
NOVEMBER 7, 2024
Pharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these disparities.
Gilead's CAR-T sales stagnate as Trodelvy takes another impairment hit
Fierce Pharma
NOVEMBER 7, 2024
Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its bread-and-butter antirival franchise with an eye on the potential of its long-acting | Gilead's CAR-T therapies Yescarta and Tecartus have stayed relatively flat all year with its Yescarta facing a 1% decline over the third quarter due to competition.
CerpassRx, Waltz Health team up to bring down specialty pharmacy costs
Fierce Healthcare
NOVEMBER 7, 2024
CerpassRx, an independent pharmacy benefit manager, is teaming up with Waltz Health to launch a new AI-powered tool that aims to better manage specialty drug spending. | CerpassRx, an independent pharmacy benefit manager, is teaming up with Waltz Health to launch a new AI-powered tool that aims to better manage specialty drug spending.
Sparked by FDA expansion, Sarepta's Elevidys takes another leap in sales
Fierce Pharma
NOVEMBER 7, 2024
An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) Elevidys has sparked a new surge in sales for the gene therapy. | An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy Elevidys has sparked a new surge in sales. The gene therapy's $181 million sales in the third quarter beat analysts' expectations as it made a 48% sequential leap.
Let's personalize your content